Want to see AMPE full AI Analyst Report?
Ampio Pharmaceuticals (AMPE) Income Statement
Ampio Pharmaceuticals Income Statement
Last quarter (Q4 2023), Ampio Pharmaceuticals's total revenue was $245.00K. In Q4, Ampio Pharmaceuticals's net income was $-2.05M. See Ampio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -250.00K | $ -2.08M | $ -1.09M | $ -1.18M | $ -1.27M | |
| $ 9.27M | $ 18.30M | $ 19.48M | $ 15.83M | $ 17.30M | |
| Depreciation and Amortization | $ 122.00K | $ 1.05M | $ 1.09M | $ 1.18M | $ 1.27M |
| $ -8.51M | $ -23.16M | $ -15.98M | $ -14.66M | $ -12.28M | |
| $ -9.52M | $ -20.38M | $ -20.57M | $ -15.83M | $ -18.58M | |
| $ 886.00K | $ 4.04M | $ 3.50M | $ -60.00K | $ 4.95M | |
| $ -8.63M | $ -16.34M | $ -17.07M | $ -15.89M | $ -13.63M | |
| $ -8.63M | $ -16.34M | $ -17.07M | $ -15.89M | $ -13.63M | |
| Per Share Metrics | |||||
| Basic EPS | $ -10.67 | $ -11.24 | $ -18.79 | $ -28.63 | $ -18.32 |
| Diluted EPS | $ -10.66 | $ -29.32 | $ -18.59 | $ -27.59 | $ -18.32 |
| Weighted Average Shares Outstanding | 809.00K | 557.00K | 664.33K | 576.15K | 474.03K |
| Weighted Average Shares Outstanding (Diluted) | 810.11K | 753.62K | 683.21K | 595.41K | 474.03K |
Currency in USD